Search Results - "Galsky, Matt D" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

ENERGIZE: a Phase III study of neoadjuvant chemotherapy alone or with nivolumab with/without linrodostat mesylate for muscle-invasive bladder cancer

ENERGIZE: a Phase III study of neoadjuvant chemotherapy alone or with nivolumab with/without linrodostat mesylate for muscle-invasive bladder cancer

by Sonpavde, Guru, Necchi, Andrea, Gupta, Shilpa, Steinberg, Gary D, Gschwend, Juergen E, Van Der Heijden, Michiel Simon, Garzon, Nathalie, Ibrahim, Mohammed, Raybold, Bradley, Liaw, Danny, Rutstein, Mark, Galsky, Matt D
Published in Future oncology (London, England) (01.01.2020)

Get full text

Journal Article

First results from the phase 3 CheckMate 274 trial of adjuvant nivolumab vs placebo in patients who underwent radical surgery for high-risk muscle-invasive urothelial carcinoma (MIUC)

First results from the phase 3 CheckMate 274 trial of adjuvant nivolumab vs placebo in patients who underwent radical surgery for high-risk muscle-invasive urothelial carcinoma (MIUC)

by Bajorin, Dean F., Witjes, Johannes Alfred, Gschwend, Jürgen, Schenker, Michael, Valderrama, Begoña P., Tomita, Yoshihiko, Bamias, Aristotelis, Lebret, Thierry, Shariat, Shahrokh, Park, Se Hoon, Ye, Dingwei, Agerbaek, Mads, Collette, Sandra, Unsal-Kacmaz, Keziban, Zardavas, Dimitrios, Koon, Henry B., Galsky, Matt D.
Published in Journal of clinical oncology (20.02.2021)

Get full text

Journal Article

Treatment of Metastatic Urothelial Carcinoma After Previous Cisplatin-based Chemotherapy for Localized Disease: A Retrospective Comparison of Different Chemotherapy Regimens

Treatment of Metastatic Urothelial Carcinoma After Previous Cisplatin-based Chemotherapy for Localized Disease: A Retrospective Comparison of Different Chemotherapy Regimens

by Do, Olivia A., Ferris, Lorin A., Holt, Sarah K., Ramos, Jorge D., Harshman, Lauren C., Plimack, Elizabeth R., Crabb, Simon J., Pal, Sumanta K., De Giorgi, Ugo, Ladoire, Sylvain, Baniel, Jack, Necchi, Andrea, Vaishampayan, Ulka N., Bamias, Aristotelis, Bellmunt, Joaquim, Srinivas, Sandy, Dorff, Tanya B., Galsky, Matt D., Yu, Evan Y.
Published in Clinical genitourinary cancer (01.04.2021)

Get full text

Journal Article

SGNTUC-019: Phase 2 basket study of tucatinib and trastuzumab in previously treated solid tumors with HER2 alterations—Urothelial cancer cohort (trial in progress)

SGNTUC-019: Phase 2 basket study of tucatinib and trastuzumab in previously treated solid tumors with HER2 alterations—Urothelial cancer cohort (trial in progress)

by Galsky, Matt D., Ramos, Jorge, Tan, Qianwen, Yu, Evan Y.
Published in Journal of clinical oncology (20.02.2022)

Get full text

Journal Article

Black patient representation in anti-cancer drug development

Black patient representation in anti-cancer drug development

by Karol, Alexander B., Paredes, Rodrigo, Fujiwara, Yu, Argulian, Anna, Joshi, Himanshu, Galsky, Matt D.
Published in Journal of clinical oncology (01.06.2024)

Get full text

Journal Article

C-reactive protein (CRP) as a prognostic biomarker in patients with bladder cancer: A meta-analysis

C-reactive protein (CRP) as a prognostic biomarker in patients with bladder cancer: A meta-analysis

by Fujiwara, Yu, Karol, Alexander B., Reford, Emma, Joshi, Himanshu, Doroshow, Deborah Blythe, Galsky, Matt D.
Published in Journal of clinical oncology (01.06.2023)

Get full text

Journal Article

A phase 2 basket study of tucatinib and trastuzumab in previously treated solid tumors with HER2 alterations: Urothelial cancer cohort (SGNTUC-019)

A phase 2 basket study of tucatinib and trastuzumab in previously treated solid tumors with HER2 alterations: Urothelial cancer cohort (SGNTUC-019)

by Yu, Evan Y., Jin, Fan, Ramos, Jorge, Tan, Qianwen, Galsky, Matt D.
Published in Journal of clinical oncology (20.02.2023)

Get full text

Journal Article

Local and systemic therapies for renal cell carcinoma with brain metastases: A single-institution series

Local and systemic therapies for renal cell carcinoma with brain metastases: A single-institution series

by Ganta, Teja, Miller, Eric James, Anker, Jonathan Forrest, Galsky, Matt D., Tsao, Kai
Published in Journal of clinical oncology (20.02.2023)

Get full text

Journal Article

Phase 3 study of disitamab vedotin with pembrolizumab vs chemotherapy in patients with previously untreated locally advanced or metastatic urothelial carcinoma that expresses HER2 (DV-001)

Phase 3 study of disitamab vedotin with pembrolizumab vs chemotherapy in patients with previously untreated locally advanced or metastatic urothelial carcinoma that expresses HER2 (DV-001)

by Galsky, Matt D., Grande, Enrique, Necchi, Andrea, Drakaki, Alexandra, Loriot, Yohann, Franco, Sonia, Ichimaru, Mari, Zhang, Wei, Powles, Thomas
Published in Journal of clinical oncology (01.06.2024)

Get full text

Journal Article

ANTICIPATE: A phase I/II, open-label, multicenter study to evaluate the safety and efficacy of oral APL-1202 in combination with tislelizumab compared to tislelizumab alone as neoadjuvant therapy (NAC) in patients with muscle invasive bladder cancer (MIBC)

ANTICIPATE: A phase I/II, open-label, multicenter study to evaluate the safety and efficacy of oral APL-1202 in combination with tislelizumab compared to tislelizumab alone as neoadjuvant therapy (NAC) in patients with muscle invasive bladder cancer (MIBC)

by Galsky, Matt D., Sfakianos, John P., Ye, Ding-Wei, Zhang, Mingming
Published in Journal of clinical oncology (01.06.2022)

Get full text

Journal Article

Benchmarking maintenance therapy survival in first-line advanced urothelial carcinoma using disease modeling

Benchmarking maintenance therapy survival in first-line advanced urothelial carcinoma using disease modeling

by Galsky, Matt D., Wirtz, Heidi, Bloudek, Brian, Hepp, Zsolt, Timmons, Jack, Lenero, Enrique, Powles, Thomas
Published in Journal of clinical oncology (01.06.2022)

Get full text

Journal Article

ANTICIPATE phase I: Oral APL-1202 in combination with tislelizumab as neoadjuvant therapy in patients with muscle-invasive bladder cancer (MIBC)

ANTICIPATE phase I: Oral APL-1202 in combination with tislelizumab as neoadjuvant therapy in patients with muscle-invasive bladder cancer (MIBC)

by Galsky, Matt D., Sfakianos, John P., Ye, Ding-Wei, Song, Xiaodong, Hu, Hailong, Shore, Neal D., Zhang, Xiaoping, Zhang, Mingming
Published in Journal of clinical oncology (01.06.2023)

Get full text

Journal Article

C-reactive protein as a response biomarker to immune checkpoint blockade: A meta-analysis

C-reactive protein as a response biomarker to immune checkpoint blockade: A meta-analysis

by Karol, Alexander B, Fujiwara, Yu, D'Ovidio, Tyler J, Baldwin, Elena, Joshi, Himanshu, Doroshow, Deborah Blythe, Galsky, Matt D.
Published in Journal of clinical oncology (01.06.2023)

Get full text

Journal Article

Perioperative enfortumab vedotin (EV) plus pembrolizumab (pembro) versus chemotherapy in cisplatin-eligible patients (pts) with muscle-invasive bladder cancer (MIBC): Phase 3 KEYNOTE-B15/EV-304

Perioperative enfortumab vedotin (EV) plus pembrolizumab (pembro) versus chemotherapy in cisplatin-eligible patients (pts) with muscle-invasive bladder cancer (MIBC): Phase 3 KEYNOTE-B15/EV-304

by Hoimes, Christopher J., Loriot, Yohann, Bedke, Jens, Nishiyama, Hiroyuki, Kataria, Ritesh S., Homet Moreno, Blanca, Galsky, Matt D.
Published in Journal of clinical oncology (20.02.2023)

Get full text

Journal Article

Incidence of hepatitis associated with addition of immune checkpoint blockade to conventional solid tumor therapy: A meta-analysis of phase 3 randomized clinical trials

Incidence of hepatitis associated with addition of immune checkpoint blockade to conventional solid tumor therapy: A meta-analysis of phase 3 randomized clinical trials

by Fujiwara, Yu, Horita, Nobuyuki, Namkoong, Ho, Miyashita, Hirotaka, Harrington, Matthew, Galsky, Matt D.
Published in Journal of clinical oncology (20.05.2021)

Get full text

Journal Article

SGNTUC-019: Phase II basket study of tucatinib (TUC) and trastuzumab (Tras) in previously treated solid tumors with HER2 alterations: Urothelial cancer cohort (trial in progress)

SGNTUC-019: Phase II basket study of tucatinib (TUC) and trastuzumab (Tras) in previously treated solid tumors with HER2 alterations: Urothelial cancer cohort (trial in progress)

by Yu, Evan Y., Kang, Vicky, Walker, Luke N., Galsky, Matt D.
Published in Journal of clinical oncology (20.02.2021)

Get full text

Journal Article

Tumor characteristics associated with detectable circulating tumor DNA preoperatively in patients with renal masses suspicious for RCC

Tumor characteristics associated with detectable circulating tumor DNA preoperatively in patients with renal masses suspicious for RCC

by Ben-David, Reuben, Alerasool, Parissa, Kalola, Hitasha, Tillu, Neeraja, Tsao, Kai, Galsky, Matt D., Attalla, Kyrollis, Sfakianos, John P., Wiklund, Peter, Waingankar, Nikhil, Mehrazin, Reza
Published in Journal of clinical oncology (01.02.2024)

Get full text

Journal Article

Final study analysis of PRINT: Prostate cancer intensive, non–cross-reactive therapy for CRPC

Final study analysis of PRINT: Prostate cancer intensive, non–cross-reactive therapy for CRPC

by Liaw, Bobby Chi-Hung, Joshi, Himanshu, Sheng, Tianxiang, Tsao, Che-Kai, Galsky, Matt D., Bakst, Richard Lorne, Stewart, Robert, Stock, Richard, Oh, William K.
Published in Journal of clinical oncology (01.02.2024)

Get full text

Journal Article

Phase 3 open-label, randomized, controlled study of disitamab vedotin with pembrolizumab versus chemotherapy in patients with previously untreated locally advanced or metastatic urothelial carcinoma that expresses HER2 (DV-001)

Phase 3 open-label, randomized, controlled study of disitamab vedotin with pembrolizumab versus chemotherapy in patients with previously untreated locally advanced or metastatic urothelial carcinoma that expresses HER2 (DV-001)

by Galsky, Matt D., Grande, Enrique, Necchi, Andrea, Koontz, Michael Zach, Iyer, Gopa, Campbell, Matthew T, Drakaki, Alexandra, Loriot, Yohann, Sokolowski, Kevin M., Zhang, Wei, Powles, Thomas
Published in Journal of clinical oncology (01.02.2024)

Get full text

Journal Article

Enhancing bladder cancer (BC) care through clinician and patient education

Enhancing bladder cancer (BC) care through clinician and patient education

by Jaganathan, Hamsa, Roc, Anne, Turell, Wendy, Galsky, Matt D.
Published in Journal of clinical oncology (20.05.2018)

Get full text

Journal Article

1
2
3
4
5
6
7
8
9
10
11
Next
[12]